Scarica l'app Stockscreener
1.49
1.97%
-0.03
Pre-mercato:
1.55
0.06
+4.03%
20 20 Biolabs Inc Borsa (AIDX) Ultime notizie
20/20 BioLabs licenses kidney disease prediction technology from ROKIT Healthcare - MSN
20/20 Biolabs Inc. (AIDX) Earnings Yield (TTM) - Zacks Investment Research
AIDX SEC Filings20/20 Biolabs Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Is 20/20 Biolabs (AIDX) stock a strong buy |Bond Issuance - Newser
20/20 Biolabs Inc. (AIDX) - Zacks Investment Research
20/20 Biolabs Inc. (AIDX) Gross Margin (TTM) - Zacks Investment Research
20/20 BioLabs blood test platform targeting early detection of hard-to-screen Cancers - Proactive financial news
20/20 Biolabs (NASDAQ: AIDX) cuts warrant price, registers 15.16M shares - Stock Titan
Warrant strike cut to $2.25 as 20/20 Biolabs (NASDAQ: AIDX) registers 10.1M shares - Stock Titan
Streeterville warrant repricing at 20/20 Biolabs (NASDAQ: AIDX) drops strike - Stock Titan
AIDX Price Today: 20/20 Biolabs, Inc. Stock Price, Quote & Chart - MEXC
AIDX (20/20 Biolabs) highlights rising clinical test adoption as core growth driver in latest quarterly earnings.Community Trade Ideas - Newser
How to Value 20/20 Biolabs (AIDX) Stock (Technical Strength) 2026-04-22Community Driven Stock Picks - Cổng thông tin điện tử Tỉnh Sơn La
20/20 BIOLABS INC Company Profile & Introduction - Moomoo
AIDX | 20/20 Biolabs, Inc. Common Insider Trading - Quiver Quantitative
20/20 Biolabs (AIDX) Stock Chart and Price History 2026 - MarketBeat
BIO-key International, 20/20 Biolabs, Society Pass, and Soligenix Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - ACCESS Newswire
20/20 Biolabs (NASDAQ: AIDX) resale prospectus: 10.105M shares may be sold - Stock Titan
15.16M shares available for resale as 20/20 Biolabs (NASDAQ: AIDX) direct listing - Stock Titan
[EFFECT] 20/20 Biolabs, Inc. SEC Filing - Stock Titan
AIDX: 20/20 Biolabs Inc.Comparison to Industry - Zacks Investment Research
Dividend History20/20 Biolabs Inc. (AIDX) - Zacks Investment Research
20/20 BioLabs Selected by Evexia Diagnostics to Offer OneTest™ for Cancer Through Evexia Platform - Sahm
Multi-Cancer Early Detection Test Added to Evexia Diagnostics Platform - Clinical Lab Products
Cancer test reaches 40,000 practitioners through Evexia platform - Stock Titan
20/20 BioLabs’ Multi-Cancer Early Detection Test Now Available to Evexia Diagnostics' 40,000+ U.S. Practitioners - The Desert Sun
20/20 Biolabs (AIDX) CFO receives 100,000-share stock option grant - Stock Titan
COO of 20/20 Biolabs (AIDX) granted 150,000 options at $1.88 - Stock Titan
Resale of 10.1M 20/20 Biolabs (Nasdaq: AIDX) shares amid losses - Stock Titan
20/20 Biolabs (NASDAQ: AIDX) 15.16M-share resale registration - Stock Titan
AIDX : 20/20 Biolabs Inc. Key Company Metrics & Non-finance Metrics - Zacks Investment Research
20/20 Biolabs, Inc. (AIDX) stock price, news, quote and history - Yahoo Finance Singapore
20/20 BioLabs (AIDX) Reports 17% Revenue Growth in 2025 and Eyes Significant Expansion in 2026 with AI-Powered Cancer Detection Blood Tests - Minichart
20/20 BioLabs Reports Full Year 2025 Financial Results and Recent Operational Progress - The Manila Times
All News for AIDX : 20/20 Biolabs Inc. - Zacks Investment Research
20/20 BioLabs (AIDX) grows 2025 revenue 17% and narrows annual net loss - Stock Titan
20/20 Biolabs 10-K: Revenues $2.05M, Net Loss $(3.74)M - TradingView — Track All Markets
20/20 Biolabs (NASDAQ: AIDX) outlines AI blood tests, longevity and growth - Stock Titan
20/20 Biolabs, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Maryland funds firefighter cancer tests as 20/20 lifts margins - Stock Titan
AIDX | 20/20 Biolabs, Inc. Common Institutional Ownership - Quiver Quantitative
AIDX | 20/20 Biolabs, Inc. Common Stock Data, Price & News - Quiver Quantitative
20/20 Biolabs Unchanged on News - Baystreet.ca
20/20 BioLabs announces grants for Maryland fire departments to procure OneTest - TipRanks
Maryland Fire Departments Awarded $520,000 for Cancer Screenings using 20/20 BioLabs’ OneTest ™ Multi-Cancer Early Detection Blood Test - The Manila Times
Maryland Fire Departments Awarded $520,000 for Cancer Screenings using 20/20 BioLabs' OneTest Multi-Cancer Early Detection Blood Test - Bitget
20/20 BioLabs licenses kidney disease prediction technology By Investing.com - Investing.com India
20/20 BioLabs Secure U.S. License For Advanced CKD Prediction Technology - RTTNews
0.41%
0.93%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):